Sentences with phrase «first cancer studies»

The first cancer studies are just starting in Britain and the US.

Not exact matches

The first step in the process is to surgically remove the patient's tumor and ensure that the patient is cancer free by confirming that there is no sign of cancer on blood tests and imaging studies.

Her discovery of radium lead to the development of using X-rays in medicine, and Curie was at the forefront for cancer research, directing the first studies that used radiation to treat tumors.

I first became aware of the structure of the narratives that express world view several years before the discovery of my cancer, when I began during my sabbatical year to study congregations systematically.

The first study used in that paper was performed in the Philippines Skin and Cancer Foundation and published in the journal Dermatitis in 2008.

The first is Kit August, a Breast Cancer survivor — state winning artist, holder of several technology patents, actress, musician and currently studying toward her Phd.

A couple things about this study are worth mentioning: a) they removed cases in which symptoms of cancer occurred in the first nine months or the child died in the first year, which may be where the effects of breastfeeding are strongest (though I certainly don't know this for a fact, but it is reasonable); and b) they did not examine exclusive breastfeeding, but rather any breastfeeding (this is important as the effects of breastfeeding are known to be strongest when breastfeeding is exclusive and it is also difficult to ascertain how little or how much women were breastfeeding when any breastfeeding is the variable of interest).

Studies have found that firefighters have a higher incidence of cancer due to service than other first responders.

Baylin and Johns Hopkins scientist Michelle Vaz, Ph.D., first author on the study, suspected that the interplay of epigenetic and genetic changes may occur when normal lung cells develop into cancer, but, Baylin says, the timing of such changes was unknown.

In the first study evaluating patient - reported cosmetic outcomes in a population - based cohort of older women with breast cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long -cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long -Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long - term.

Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.

The FDA recently okayed the first therapeutic cancer vaccine, and other drugs that enlist the immune system against tumors are under study

The young women were then surveyed about their beliefs regarding cancer and followed for nine months after receiving the first dose to determine vaccination series completion; nearly 350 women participated in the study.

«This is the first comprehensive study of its kind and shows the potential to not only reduce the global cancer burden, but also guide clinical decision - making with regard to childhood vaccinations,» said Marc T. Goodman, PhD, MPH, senior author of the study and director of Cancer Prevention and Genetics at the Cedars - Sinai Samuel Oschin Comprehensive Cancer Instcancer burden, but also guide clinical decision - making with regard to childhood vaccinations,» said Marc T. Goodman, PhD, MPH, senior author of the study and director of Cancer Prevention and Genetics at the Cedars - Sinai Samuel Oschin Comprehensive Cancer InstCancer Prevention and Genetics at the Cedars - Sinai Samuel Oschin Comprehensive Cancer InstCancer Institute.

«It increases the number of HPV16 genomes studied by an order of magnitude and is the first large study to evaluate variation occurring throughout the HPV16 genome at the isolate level linked to cancer development.»

Dr Claudia Wellbrock, study author and Cancer Research UK scientist at The University of Manchester and a member of the Manchester Cancer Research Centre, said: «We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow raCancer Research UK scientist at The University of Manchester and a member of the Manchester Cancer Research Centre, said: «We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow raCancer Research Centre, said: «We used to think that cancer cells spread by first specialising in invading other parts of the body and then change in order to grow racancer cells spread by first specialising in invading other parts of the body and then change in order to grow rapidly.

The study, published online April 16 in Nature Medicine, represents the first time a severe brainstem cancer, diffuse intrinsic pontine glioma, has been eradicated in mice with the tumor.

In this study, the SIgN team discovered for the first time that the integrity of p53 affects the production of a special cell surface protein called Major Histocompatibility Complex (MHC) class I. MHC class I molecules on the cancer cell surface serve as targets for the immune system.

They were subsequently monitored until they either developed stomach cancer, died, or the study ended (end of December 2015), whichever came first.

«Estimating from various studies that looked at increasing BMI and endometrial cancer risk, a woman with a Body Mass Index (BMI) of 40 would have approximately eight times greater risk of endometrial cancer than someone with a BMI of 25,» said first author Kristy Ward, MD, the senior gynecologic oncology fellow in the Department of Reproductive Medicine at UC San Diego School of Medicine.

Dr. Glen Weiss, M.D., M.B.A., is the first author of the study abstract: Phase Ib / II Study of Pembrolizumab plus Chemotherapy in Advanced Cancer: Results of lung cancer patients receiving (at least) 1 prior line of thestudy abstract: Phase Ib / II Study of Pembrolizumab plus Chemotherapy in Advanced Cancer: Results of lung cancer patients receiving (at least) 1 prior line of theStudy of Pembrolizumab plus Chemotherapy in Advanced Cancer: Results of lung cancer patients receiving (at least) 1 prior line of thCancer: Results of lung cancer patients receiving (at least) 1 prior line of thcancer patients receiving (at least) 1 prior line of therapy.

Studying such diseases is a good first step because they are cancers of immune cells themselves, and it's possible to analyze them with a mere blood sample.

«Our results provide evidence for clinicians to consider HRT as compared with CRT as a preferred radiation treatment in men with intermediate - risk prostate cancer and at low risk of other complications,» stated Trevor Royce, MD, MPH, radiation oncologist at Brigham and Women's Hospital and first author of the study.

The systematic review, published in Obstetrics & Gynecology on Nov. 7, is the first to combine data from multiple studies on IUDs and cervical cancer.

Surgical oncologists, or cancer surgeons, usually remove breast cancers by relying on tactile feedback and radiologic images of the tumor, such as mammograms and ultrasound images, said M. Catherine Lee, MD, FACS, coauthor of the first study and associate professor of surgery at H. Lee Moffitt Cancer Center, Tampa,cancer surgeons, usually remove breast cancers by relying on tactile feedback and radiologic images of the tumor, such as mammograms and ultrasound images, said M. Catherine Lee, MD, FACS, coauthor of the first study and associate professor of surgery at H. Lee Moffitt Cancer Center, Tampa,Cancer Center, Tampa, Fla..

«Our study is a real eye opener; it's the first step showing the low incidence of cancer in these large polyps, which is not as previously thought,» Dr. Gorgun said.

Peter Sasieni, at Cancer Research UK, who led the study, suggests that HPV testing should be the first step in any screening programme.

The first national study on Hispanic health risks and leading causes of death in the United States by the Centers for Disease Control and Prevention (CDC) showed that similar to non-Hispanic whites (whites), the two leading causes of death in Hispanics are heart disease and cancer.

The first author of the Science paper is Laura Gaydos, a graduate student in Strome's lab at UC Santa Cruz who led the study for her Ph.D. thesis and is now a postdoctoral researcher at Fred Hutchinson Cancer Research Center in Seattle.

While previous studies have surveyed the genomic characteristics of tumors confined to the prostate gland, the new study is the first to focus on metastatic hormone resistant prostate cancers, which can be difficult to treat because they often develop resistance to standard treatments.

Spearheaded by first author Christopher McNair, PhD, a graduate student in the laboratory of Dr. Knudsen, the study undertook an extensive analysis of tumor samples and cell - free DNA samples from patients with advanced, lethal - stage prostate cancer.

However, a new study published in the journal Environment International, has estimated for the first time the potential cancer risk by age group through non-dietary ingestion and dermal exposure to third hand smoke.

The first study will examine these patients over time, in order to analyze other important variables such as melanoma relapse, mortality, resistance to treatment, development of a second melanoma or other cancers, and metastasis, including spread of the cancer to nearby lymph nodes (sentinel nodes).

«This is the first study to show how effective these ultrasound - guided blocks can now be for breast cancer surgery.

«This is the first large prospective multicenter study that was specifically constructed to look at the relationship between sleep apnea and a specific cancer,» said lead author Miguel Ángel Martinez - Garcia, MD, PhD, from the Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Raquel Oliveira, first author of this study, explains: «Many cancer cells have these type of chromosomal abnormalities and we now show that this can bring additional problems every time a cell divides.»

«Our work could also contribute to ongoing efforts in immuno - oncology and the treatment of cancer,» explained Tao Xu, postdoctoral scholar in Ding's laboratory and first author of the study.

Untreated severe obstructive sleep apnea (OSA) is associated with increased aggressiveness of malignant cutaneous melanoma, according to the first multicenter prospective study on the relationship between sleep - disordered breathing (apnea or hypopnea) and cancer.

The study not only shows that NPTX2 is active in kidney cancer, but is the first to reveal that the gene is over-expressed in any human cancer.

This is the first to study to quantify the beliefs and attitudes about CAM in cancer patients.

Professor Johann de Bono, Regius Professor of Cancer Research at The Institute of Cancer Research, London, and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, said, «Our study identifies, for the first time, genetic changes that allow prostate cancer cells to become resistant to the precision medicine olaCancer Research at The Institute of Cancer Research, London, and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, said, «Our study identifies, for the first time, genetic changes that allow prostate cancer cells to become resistant to the precision medicine olaCancer Research, London, and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, said, «Our study identifies, for the first time, genetic changes that allow prostate cancer cells to become resistant to the precision medicine olacancer cells to become resistant to the precision medicine olaparib.

The first large U.S. study aimed at resolving an ongoing debate about the best way to treat an early sign of breast cancer will launch later this year under the direction of a Duke Cancer Institute investicancer will launch later this year under the direction of a Duke Cancer Institute investiCancer Institute investigator.

According to the authors, this is the first study to examine long - term outcomes of patients with low - vs. intermediate - risk prostate cancer managed on active surveillance.

«This is the first study that offers a demonstrable solution for cancer patients with traumatic stress symptoms.

Study co-leader Wyndham Wilson, M.D., Ph.D., NCI Center for Cancer Research, added, «This is the first clinical study to demonstrate the importance of precision medicine in lymphomas.&rStudy co-leader Wyndham Wilson, M.D., Ph.D., NCI Center for Cancer Research, added, «This is the first clinical study to demonstrate the importance of precision medicine in lymphomas.&rstudy to demonstrate the importance of precision medicine in lymphomas.»

Horvath and Tell's research is the first reported study to compare breast cancer subtypes and gene expression patterns associated with STAT3 in the tumors of human patients.

This is the first study to use PWS to predict a cancer prognosis, the likely course of the disease.

«We've had luck with other types of cancer in removing the brakes on the immune system to allow it to fight the tumors, but this has not been the case with glioblastoma,» said study author Anhua Wu, MD, PhD, of the First Hospital of China Medical University in Shenyang, China.

The three Ras genes found in humans — H - Ras, K - Ras and N - Ras — were among the first to be linked to cancer development, and a new study led by VCU Massey Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected prcancer development, and a new study led by VCU Massey Cancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected prCancer Center researcher Paul Dent, Ph.D., has shown the recently approved breast cancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected prcancer drug neratinib can block the function of Ras as well as several other oncogenes through an unexpected process.

In the first study to report on the association of aspirin use with breast cancer outcomes in a large patient population, researchers examined the pattern of aspirin use, cancer pathology and overall survival in 1,000 patients treated at the Abramson Cancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative cacancer outcomes in a large patient population, researchers examined the pattern of aspirin use, cancer pathology and overall survival in 1,000 patients treated at the Abramson Cancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative cacancer pathology and overall survival in 1,000 patients treated at the Abramson Cancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative caCancer Center of the University of Pennsylvania and diagnosed with breast cancers, including receptor positive, HER2 - positive and triple negative cancers.